Imunon schedules third-quarter financial results call

IMNN•2026-11-02

Imunon will host a call on Nov. 12, 2026, at 11 a.m. EST, with an update on Phase 3 development of IMNN-001 in newly diagnosed advanced ovarian cancer.

1. Call details

Imunon will host its third-quarter 2026 financial results conference call on Nov. 12, 2026, at 11 a.m. EST. The call will include an update on Phase 3 development of IMNN-001 in newly diagnosed advanced ovarian cancer.

Imunon schedules third-quarter financial results call

1. Call details

Related News

Booking Holdings publishes update to financial calendar

OFG Bancorp increases quarterly cash dividend to $0.40

NatWest publishes Q3 2026 results call transcript

US research roundup: Eli Lilly, General Dynamics, S&P Global

BioVie to present new biomarker data from Phase 2 bezisterim Long COVID trial